Detalles de la búsqueda
1.
Computational protein design to reengineer stromal cell-derived factor-1α generates an effective and translatable angiogenic polypeptide analog.
Circulation
; 124(11 Suppl): S18-26, 2011 Sep 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-21911811
2.
Stromal cell-derived factor-1alpha activation of tissue-engineered endothelial progenitor cell matrix enhances ventricular function after myocardial infarction by inducing neovasculogenesis.
Circulation
; 122(11 Suppl): S107-17, 2010 Sep 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-20837901
3.
Myocardial tissue elastic properties determined by atomic force microscopy after stromal cell-derived factor 1α angiogenic therapy for acute myocardial infarction in a murine model.
J Thorac Cardiovasc Surg
; 143(4): 962-6, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22264415
4.
Oxygen-dependent quenching of phosphorescence used to characterize improved myocardial oxygenation resulting from vasculogenic cytokine therapy.
J Appl Physiol (1985)
; 110(5): 1460-5, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21292844
5.
Spliced stromal cell-derived factor-1α analog stimulates endothelial progenitor cell migration and improves cardiac function in a dose-dependent manner after myocardial infarction.
J Thorac Cardiovasc Surg
; 140(5): 1174-80, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20951261
6.
Tissue-engineered pro-angiogenic fibroblast scaffold improves myocardial perfusion and function and limits ventricular remodeling after infarction.
J Thorac Cardiovasc Surg
; 140(3): 667-76, 2010 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-20363480
Resultados
1 -
6
de 6
1
Próxima >
>>